In acute myeloid leukemia (AML), one of the strongest risk factor used for risk stratification is the presence of an internal tandem duplication in the FLT3 gene (FLT3-ITD), which occurs in 20-30% of the cases [1–4]. The gene discussed is FLT3; the disease is acute myeloid leukemia.